NCT02247726View on ClinicalTrials.gov

RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

Saline Placebo (0.5mL injection)

DRUG

RSV F vaccine (0.5mL injection)

Trial Locations (7)

15213

Magee- Womens Hospital of UPMC, Pittsburgh

27705

Duke University, Durham

66160

University of Kansas Medical Center Research Institute, Kansas City

67502

Hutchinson Clinic, P.A., Hutchinson

68701

Meridian Clinical Research, Norfolk

77030

Baylor College of Medicine, Houston

83687

Advanced Specialty Research, Nampa

Sponsors

Lead Sponsor

Novavax
All Listed Sponsors
lead

Novavax

INDUSTRY

NCT02247726 - RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women. | Biotech Hunter | Biotech Hunter